Metastasectomy without Systemic Therapy in Metastatic Renal Cell Carcinoma: Comparison with Conservative Treatment

Publisher： Karger

E-ISSN： 1423-0399|79|2|145-151

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.79, Iss.2, 2007-09, pp. : 145-151

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted Therapy in the Treatment of Metastatic Renal Cell Cancer

By  

Oncology, Vol. 77, Iss. 1, 2010-02 ,pp. : 122-131

Karger

Access to resources Recommend Favorite

Systemic treatment in advanced/metastatic hepatocellular carcinoma in the era of targeted therapy

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 25, Iss. 6, 2010-06 ,pp. : 1023-1025

John Wiley & Sons Inc

Access to resources Recommend Favorite

Continuous Therapy with Sunitinib in Patients with Metastatic Renal Cell Carcinoma

By  

Oncology Research and Treatment, Vol. 31, Iss. 8-9, 2008-07 ,pp. : 485-485

Karger

Access to resources Recommend Favorite

Duration of Targeted Therapy for Metastatic Renal Cell Carcinoma: A Review of Current Practices

By  

Oncology, Vol. 82, Iss. 4, 2012-03 ,pp. : 189-196

Karger

Access to resources Recommend Favorite

Spontaneous Regression of Hepatic Metastases after Nephrectomy and Metastasectomy of Renal Cell Carcinoma

By  

Urologia Internationalis, Vol. 66, Iss. 2, 2001-02 ,pp. : 119-120

Karger

Access to resources Recommend Favorite